172 related articles for article (PubMed ID: 35323643)
1. Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs.
Tsamouri MM; Durbin-Johnson BP; Culp WTN; Palm CA; Parikh M; Kent MS; Ghosh PM
Metabolites; 2022 Feb; 12(3):. PubMed ID: 35323643
[TBL] [Abstract][Full Text] [Related]
2. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM
BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489
[TBL] [Abstract][Full Text] [Related]
3. Assessment of urinary 15-F
Woolcock AD; Cheney A; Deshuillers P; Knapp D; Moore GE
J Vet Intern Med; 2020 Nov; 34(6):2454-2459. PubMed ID: 32936493
[TBL] [Abstract][Full Text] [Related]
4. Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction.
Mochizuki H; Shapiro SG; Breen M
Vet Pathol; 2016 Jul; 53(4):764-72. PubMed ID: 26574558
[TBL] [Abstract][Full Text] [Related]
5. LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer.
Yang M; Liu X; Tang X; Sun W; Ji Z
Front Oncol; 2023; 13():1160965. PubMed ID: 37256175
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of lymphocyte-specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
Pinard CJ; Stegelmeier AA; Bridle BW; Mutsaers AJ; Wood RD; Wood GA; Woods JP; Hocker SE
Vet Comp Oncol; 2022 Jun; 20(2):427-436. PubMed ID: 34797014
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
[TBL] [Abstract][Full Text] [Related]
8. Vaginal swab cytology as a diagnostic tool for neoplasia of the lower urinary tract in 5 dogs.
Kao S; Barger A; Garrett LD
Can Vet J; 2022 Dec; 63(12):1221-1225. PubMed ID: 36467378
[TBL] [Abstract][Full Text] [Related]
9.
Sakai K; Maeda S; Saeki K; Yoshitake R; Goto-Koshino Y; Nakagawa T; Nishimura R; Yonezawa T; Matsuki N
Vet Pathol; 2020 Jan; 57(1):56-65. PubMed ID: 31640537
[TBL] [Abstract][Full Text] [Related]
10. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
11. Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma.
Mochizuki H; Shapiro SG; Breen M
PLoS One; 2015; 10(12):e0144170. PubMed ID: 26649430
[TBL] [Abstract][Full Text] [Related]
12. Changes in Urinary Exosomal Nuclear Matrix Protein-22 in Dogs With Urothelial Carcinoma: A Pilot Study.
Shin JH; An JH; Park SM; Lim GH; Seo KW; Youn HY
In Vivo; 2024; 38(1):190-195. PubMed ID: 38148062
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
[TBL] [Abstract][Full Text] [Related]
14. Untargeted Metabolomics Pilot Study Using UHPLC-qTOF MS Profile in Sows' Urine Reveals Metabolites of Bladder Inflammation.
Pousinis P; Virgiliou C; Mouskeftara T; Chalvatzi S; Kroustallas F; Panteris E; Papadopoulos GA; Fortomaris P; Cernat M; Leontides L; Begou O
Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557224
[TBL] [Abstract][Full Text] [Related]
15. Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.
Kamada M; Koshikawa N; Minegishi T; Kawada C; Karashima T; Shuin T; Seiki M
Cancer Sci; 2015 Dec; 106(12):1730-7. PubMed ID: 26450632
[TBL] [Abstract][Full Text] [Related]
16. Identification of canine mammary tumor-associated metabolites using untargeted metabolomics.
Yu C; Zheng HH; Zhang YZ; Du CT; Xie GH
Theriogenology; 2023 Nov; 211():84-96. PubMed ID: 37603937
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three techniques for the diagnosis of urinary tract infections in dogs with urolithiasis.
Gatoria IS; Saini NS; Rai TS; Dwivedi PN
J Small Anim Pract; 2006 Dec; 47(12):727-32. PubMed ID: 17201824
[TBL] [Abstract][Full Text] [Related]
18. Identification of Canine Pyometra-Associated Metabolites Using Untargeted Metabolomics.
Zheng HH; Du CT; Zhang YZ; Yu C; Huang RL; Tang XY; Xie GH
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430638
[TBL] [Abstract][Full Text] [Related]
19. Candidate urinary biomarkers show promise for distinguishing between calcium oxalate versus struvite urolithiasis in dogs.
Xu C; Yang Y; Shao Z; Ren R; Zhang Y; Jin Y; Shi H
Am J Vet Res; 2024 Feb; ():1-12. PubMed ID: 38301355
[TBL] [Abstract][Full Text] [Related]
20. Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma.
Miyake M; Owari T; Hori S; Nakai Y; Fujimoto K
Res Rep Urol; 2018; 10():251-261. PubMed ID: 30588457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
